News search
|
Research 22 May 2019 CNIC scientists have developed a new genetic tool that significantly facilitates the study of gene function in physiological conditions and disease. |
|
Research 26 Mar 2019 The results, published in JACC, demonstrate the potential of this technology to generate images of the inflammation associated with systemic atherosclerosis; this information will be useful for the study of early stages of this disease and will help to identify individuals who will benefit from early medical intervention |
|
Research 12 Mar 2019 This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease |
|
Research 30 Jan 2019 Neutrophils are the body’s main line of defense, but their action can also damage healthy cells in the cardiovascular system |
|
Research 16 Nov 2018 The study results, published in the journal Nature Communications, identify several proteins implicated in this disease |
|
Research 10 Oct 2018 CNIC researchers have discovered that the immune system is important not only in the defense against disease but also for the day-to-day function of a healthy organism |
|
About the CNIC 25 Oct 2017 Dr. Sabio leads a research group at the Carlos III National Cardiovascular Research Center (CNIC) whose main line of research are diseases related to obesity, like cardiovascular diseases, diabetes and liver cancer. |
|
Research 3 Oct 2017 The PESA study shows that people who regularly eat a ‘low energy’ breakfast (supplying less than 5% of recommended daily calorie intake) double their risk of developing atherosclerosis independently of classical cardiovascular risk factors |
|
Research 24 Jul 2017 CNIC researchers show the value of total atherosclerosis burden for the identification of individuals at risk of cardiovascular disease |
|
About the CNIC 1 Jun 2017 Dr. Ibáñez, Director of Clinical Research at the CNIC, has received an award for his contribution to the fight against cardiovascular diseases |
- ‹ previous
- 8 of 9
- next ›
















